455 related articles for article (PubMed ID: 18452527)
41. Broad band UVA: a possible reliable alternative to PUVA in the treatment of early-stage mycosis fungoides.
El Mofty M; Ramadan S; Fawzy MM; Hegazy RA; Sayed S
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):274-7. PubMed ID: 22971197
[TBL] [Abstract][Full Text] [Related]
42. Targeted UVB phototherapy for psoriasis: a preliminary study.
Lapidoth M; Adatto M; David M
Clin Exp Dermatol; 2007 Nov; 32(6):642-5. PubMed ID: 17953632
[TBL] [Abstract][Full Text] [Related]
43. Clinical validation of efficacy and safety of herbal cough formula: study of herbal cough syrup.
Nesari T; Bhagwat BK; Johnson J; Bhatt NS; Chitre D
J Herb Pharmacother; 2004; 4(4):1-12. PubMed ID: 15927921
[TBL] [Abstract][Full Text] [Related]
44. Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis.
Rose RF; Turner D; Goodfield MJ; Goulden V
Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):153-5. PubMed ID: 19438995
[TBL] [Abstract][Full Text] [Related]
45. Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results.
Papageorgiou P; Clayton W; Norwood S; Chopra S; Rustin M
Br J Dermatol; 2008 Sep; 159(3):628-32. PubMed ID: 18565174
[TBL] [Abstract][Full Text] [Related]
46. Low-dose UVA phototherapy for treatment of localized scleroderma.
Kerscher M; Volkenandt M; Gruss C; Reuther T; von Kobyletzki G; Freitag M; Dirschka T; Altmeyer P
J Am Acad Dermatol; 1998 Jan; 38(1):21-6. PubMed ID: 9448200
[TBL] [Abstract][Full Text] [Related]
47. Treatment of psoriasis with light and heat energy (LHE): a preliminary study.
Leviav A; Wolf R; Vilan A
Dermatol Online J; 2004 Oct; 10(2):4. PubMed ID: 15530294
[TBL] [Abstract][Full Text] [Related]
48. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of UVA1 phototherapy in 230 patients with various skin diseases.
Rombold S; Lobisch K; Katzer K; Grazziotin TC; Ring J; Eberlein B
Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):19-23. PubMed ID: 18201353
[TBL] [Abstract][Full Text] [Related]
50. Phototherapy: a promising treatment option for skin sclerosis in scleroderma?
Sunderkötter C; Kuhn A; Hunzelmann N; Beissert S
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii52-iii54. PubMed ID: 16987838
[TBL] [Abstract][Full Text] [Related]
51. [Long-term effects of glatiramer acetate in multiple sclerosis].
Brochet B
Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses.
Engin B; Oguz O
Int J Dermatol; 2005 Apr; 44(4):337-9. PubMed ID: 15811091
[TBL] [Abstract][Full Text] [Related]
53. The percentage of patients achieving PASI 75 after 1 month and remission time after climatotherapy at the Dead Sea.
Harari M; Novack L; Barth J; David M; Friger M; Moses SW
Int J Dermatol; 2007 Oct; 46(10):1087-91. PubMed ID: 17910722
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus.
Erceg A; Bovenschen HJ; van de Kerkhof PC; de Jong EM; Seyger MM
J Am Acad Dermatol; 2009 Apr; 60(4):626-32. PubMed ID: 19293010
[TBL] [Abstract][Full Text] [Related]
55. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells.
Camacho NR; Sánchez JE; Martin RF; González JR; Sánchez JL
J Am Acad Dermatol; 2001 Nov; 45(5):697-9. PubMed ID: 11606918
[TBL] [Abstract][Full Text] [Related]
56. Ultraviolet A in vitiligo.
El-Mofty M; Mostafa W; Youssef R; El-Fangary M; Elramly AZ; Mahgoub D; Fawzy M
Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):214-6. PubMed ID: 16869873
[TBL] [Abstract][Full Text] [Related]
57. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients.
Lu TY; Ng KP; Cambridge G; Leandro MJ; Edwards JC; Ehrenstein M; Isenberg DA
Arthritis Rheum; 2009 Apr; 61(4):482-7. PubMed ID: 19333973
[TBL] [Abstract][Full Text] [Related]
58. Assessment of the mobile delivery of infrared light (1100-1800 nm) for the treatment of facial and neck skin laxity.
Alexiades-Armenakas M
J Drugs Dermatol; 2009 Mar; 8(3):221-6. PubMed ID: 19271367
[TBL] [Abstract][Full Text] [Related]
59. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
Kikuchi K; Wakamatsu K; Tada Y; Komine M; Ito S; Tamaki K
Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
[TBL] [Abstract][Full Text] [Related]
60. Narrowband UVB (311 nm, TL01) phototherapy for pityriasis lichenoides.
Aydogan K; Saricaoglu H; Turan H
Photodermatol Photoimmunol Photomed; 2008 Jun; 24(3):128-33. PubMed ID: 18477131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
